Krebs Biochemicals & Industries Ltd
₹57.04
(-4.65%)
Wed, 04 Mar 2026, 11:12 pm
Health Technology
Pharmaceuticals: Major
24.5KKrebs Biochemicals & Industries Debt to Equity Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price to book ratio | 0.56 | 0.54 | 0.34 | 0.32 | 0.66 | 0.76 | 0.92 | 1.68 | 0 | 10.87 | 127.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price to sales ratio | 1.74 | 0.89 | 0.62 | 0.30 | 0.69 | 0.43 | 0.29 | 0.92 | 0 | 109.41 | 68.11 | 6.89 | 4.13 | 4.55 | 3.31 | 5.11 | 2.31 | 2.61 | 3.32 |
| Price to cash flow ratio | 3.49 | 0 | 0 | 0 | 0 | 14.41 | 2.08 | 2.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 1.54B | 1.28B | 1.09B | 971.01M | 1.17B | 1.16B | 1.07B | 1B | 1.39B | 1.67B | 1.85B | 2.81B | 2.29B | 2.13B | 2.85B | 4.52B | 3.05B | 3.25B | 3.56B |
| Enterprise value to EBITDA ratio | 187.24 | 10.71 | 11.75 | 0 | 28.09 | 564.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 1.19 | 0.95 | 0.86 | 1.60 | 1.89 | 2.12 | 3.78 | 11.66 | 0 | 2.42 | 43.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | -8.54 | -11.16 | -59.72 | -11.60 | -15.44 | -55.06 | 0 | -594.53 | -288.01 | -234.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Krebs Biochemicals & Industries Ltd Debt to Equity Ratio
The Krebs Biochemicals & Industries Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Krebs Biochemicals & Industries Ltd's valuation, profitability, and overall financial performance. Tracking the Krebs Biochemicals & Industries Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Krebs Biochemicals & Industries Ltd (NSE: KREBSBIO, BSE: 524518) is currently trading at ₹57.04, with a market capitalization of ₹1.25B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Krebs Biochemicals & Industries Ltd Debt to Equity Ratio is essential for fundamental analysis.
Krebs Biochemicals & Industries Ltd Debt to Equity Ratio Current Value
The current Krebs Biochemicals & Industries Ltd Debt to Equity Ratio stands at 0.
The Krebs Biochemicals & Industries Ltd Debt to Equity Ratio remains stable, indicating consistent financial performance.
Krebs Biochemicals & Industries Ltd Debt to Equity Ratio Historical Trend
The Krebs Biochemicals & Industries Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0
The decline in Krebs Biochemicals & Industries Ltd Debt to Equity Ratio indicates improving financial efficiency or better earnings growth.
What Krebs Biochemicals & Industries Ltd Debt to Equity Ratio Indicates for Investors
The Krebs Biochemicals & Industries Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Krebs Biochemicals & Industries Ltd Debt to Equity Ratio Analysis Summary
The Krebs Biochemicals & Industries Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Krebs Biochemicals & Industries Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Krebs Biochemicals & Industries Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800